Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy
about
5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failureA population-specific HTR2B stop codon predisposes to severe impulsivityHigh molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodelingPlasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors.Predictive in silico studies of human 5-hydroxytryptamine receptor subtype 2B (5-HT2B) and valvular heart diseaseFunctional polymorphisms in genes of the Angiotensin and Serotonin systems and risk of hypertrophic cardiomyopathy: AT1R as a potential modifier.Serotonin receptors and heart valve disease--it was meant 2B.Serotonin potentiates transforming growth factor-beta3 induced biomechanical remodeling in avian embryonic atrioventricular valves.Potential drug targets for calcific aortic valve disease.The cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure.Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects.Selective serotonin reuptake inhibitor use is associated with right ventricular structure and function: the MESA-right ventricle study.Mechanisms of calcification in aortic valve disease: role of mechanokinetics and mechanodynamicsLorcaserin (Belviq): A Selective Serotonin 5-HT2C Agonist In the Treatment of Obesity.Origin of cardiac fibroblasts and the role of periostin.Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?Serotonin paracrine signaling in tissue fibrosisDistinct signaling pathways activated by "extracellular" and "intracellular" serotonin in heart valve development and disease.Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development.Depression and cardiovascular disease in women: is there a common immunological basis? A theoretical synthesis.Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents.Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling.Serotonin and catecholamines in the development and progression of heart valve diseases.Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers.Influence of 5-HT(2) receptor agonist on cardiac pumping function of trained offspring of trained rats.Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells.Conducting the G-protein Coupled Receptor (GPCR) Signaling Symphony in Cardiovascular Diseases: New Therapeutic ApproachesAugmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6.Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice.β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells.5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation.Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human.Elevated Serotonin Interacts with Angiotensin-II to Result in Altered Valve Interstitial Cell Contractility and Remodeling.Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice.Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.Carcinoid syndrome: update on the pathophysiology and treatment
P2860
0ef16c34830db27b130cf40aa073c03ec388bad83850bfc870207ab8f8541e356712a9423b40dd6b395b554c906ea66d8ff94e6b1c0e5e760514c21e4b0583c87fb59445fcccf0b6a6362b56022354328abd60596749bf7d6699cd6532d7633f8ecba030acc64e05f9b4e0a502d8862173e52521bde65122b752a22c996cf021dea6217e191dd219fa72964fbea405e6ea94e9d337854c0d8306b132609592efbfcea58f13ce05cb4e07e17963503c9de9e41f92c6449abe0fd8aadc4842326a1e1dee3c0fc6fd3eeca444bb0bcbce44e0315aa67cb22bba35497da6f5c9b33b48276ccb25e2b07f046f7a0efaf10741
P248
Q21284504-CA20851B-CD86-45BA-BD8D-E879D23AB133Q24319808-8C4E2F37-83D8-4C87-9670-E5F1FE130046Q31161236-1FC8AD85-68C5-496E-97CE-E4DEDD058AA5Q33522307-7D30FF43-BF09-4FCC-A436-AA9BF9C5A6E8Q33863285-1C6C46B2-B93A-45EC-8863-C63C02A33D4FQ34008544-04637AFB-C7A9-4710-816B-C9CC4FC45C5EQ34173511-781E4D6D-D0F0-4682-B5A8-661E1A18B9A4Q34374246-2910205D-A357-463F-9F59-E46746426D36Q34399089-139B655D-6156-4A52-B0C4-6FB933002EE7Q34429191-A6458A0F-522A-449B-83E8-177D2F9416AFQ34661779-F8F76E63-12FF-496C-AB10-83DDC9344467Q35763631-3ACAEC09-22B5-4325-BD82-1133C443A859Q36857772-FE9791C8-3401-44C3-A179-145F7B5F17B0Q37310802-A80D1104-B085-4751-A881-72B3FB423F93Q37628341-4CB708B6-0FE1-4C73-AAB6-98F5B0FF61DEQ37794503-5CF6F0CD-D252-4407-AC44-A69225238F88Q38046798-4B39D7B3-F190-4FBC-8C90-3ED20C1980A5Q38049023-593A52BD-7BB8-40B4-8F5E-8DA9BD02533FQ38100690-F8D91819-6B87-4A84-948A-AAFC97116A53Q38112347-C3CACCE0-95C0-4F20-9663-9163A1886A84Q38186686-8A24AEAB-8E54-40C9-832D-38C7AF1E3587Q38219851-7B729362-3023-454A-91CF-7FD9F8C63410Q38509926-DD704A30-8880-4AF2-8B37-6795B320DEF8Q38634250-73BE56DA-0809-44D2-AA6D-BEF13C1A0E68Q38648544-BE0D767C-7C3F-4B4D-BB30-279CF4F0BE94Q38930506-817480C1-E611-41D7-BF11-1E5078900F39Q39223640-8F8FB508-B263-413A-A6C8-890FDACE5266Q39835304-13E7A66B-3201-4611-865B-D51670006090Q41206403-599D9D24-5B94-411B-9DDA-D615AEC167E5Q41237635-61514EC0-53D9-4B54-9076-A6D436B052ADQ42043334-7FEE0E7F-B49D-4948-A51B-3A3B9B07848AQ42219763-38032527-389C-48E3-8323-7A114FD2EF9DQ42424976-26654050-B8AF-4437-A979-37900F2A769DQ43507186-B3FFF616-4B12-43BE-88A3-E48B7755A3C4Q50214900-80BF8AC6-5423-4D2E-9AF1-C531CB5CDD84Q54440509-65769722-FAB5-43AA-B335-85870441E29BQ54476060-6DE949B6-4D73-4EF3-948D-4BDCA23DA429Q58801185-5ECAED3C-BFAE-461F-8499-00459FE7578B
P2860
Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@ast
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@en
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@en-gb
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@nl
type
label
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@ast
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@en
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@en-gb
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@nl
prefLabel
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@ast
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@en
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@en-gb
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@nl
P2093
P50
P921
P1433
P1476
Serotonin and angiotensin rece ...... -dependent cardiac hypertrophy
@en
P2093
Bertrand Mettauer
Burns C Blaxall
Fabrice Jaffré
Haythem Debbabi
Jacques Callebert
Jean-Marie Launay
Stéphane Doly
Vincent Setola
P304
P356
10.1161/CIRCRESAHA.108.180976
P407
P577
2009-01-02T00:00:00Z